Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

ERIGERON BREVISCAPUS EXTRACT.

Valuable CAS - / SKIN CONDITIONING

Erigeron Breviscapus Extract is a potent botanical known for its multifaceted benefits, including significant anti-inflammatory, antioxidant, and melanin-regulating effects. It is designed to soothe sensitive skin, promote a more even skin tone by addressing hyperpigmentation, and enhance overall skin hydration.

Anti-inflammatory Antioxidant Skin Brightening Moisturizing Skin Conditioning Melanin Inhibitor

Science

This extract, rich in active constituents such as breviscapine and scutellarin, operates via several mechanisms. It effectively reduces inflammation by modulating key pro-inflammatory mediators including IL-1β, IL-6, MMP13, and NOS2. Simultaneously, it inhibits melanin formation and accelerates melanin metabolism, contributing to a brighter and more uniform complexion. Scutellarin has specifically demonstrated inhibition of TOPK activity and phosphorylation of ERK1/2 and histone H3 in melanoma cells, indicating its role in pigment regulation. Furthermore, its antioxidant properties combat oxidative stress, while its ability to increase skin moisture content addresses dryness.


Research

Low confidence
Effective range N/A
Optimal

N/A


Transparency

Not commonly dusted

The Formula

Solubility
Both
Optimal pH 6.8 – 8.5
0 7 14

Stability

Breviscapine injection shows stability in color, pH, and drug content around pH 6.8. While water solubility of components is noted at pH 8–8.5 for extraction, key active components like scutellarin are generally poorly water-soluble, preferring hot water, ethanol, or dilute alkali solutions. Formulators may need to consider advanced techniques, such as liposome preparation, to optimize its solubility and utilization.


Safety

CIR Status
Not reviewed
Sensitization risk Unknown

Erigeron breviscapus is referenced as a safe medicinal material with acute and subacute toxicity studies supporting its internal use. However, a specific cosmetic safety assessment by the CIR or SCCS is currently unavailable. A derivative, Lifeflower® Breviscapine (containing at least 90% scutellarin), holds self-affirmed GRAS status for food, beverages, and dietary supplements, but this designation does not directly extend to topical cosmetic applications.


Your Skin

Yes Normal
Yes Dry
Yes Oily
Yes Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Valuable

This ingredient presents valuable potential for comprehensive skin improvement, addressing concerns from sensitivity and dryness to hyperpigmentation, though further cosmetic-specific safety and precise topical efficacy concentration data would enhance its optimal formulation.


Related

Finding similar ingredients…